If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

Upgrades aim to improve asthma relief and COPD treatment with advanced technology.United States, January 31, 2025 -- TruNeb ...

A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline ...

Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...

a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score-matched cohort study. The study included 20,388 propensity score-matched ...

Early treatment will prevent the condition from ... worsening symptoms, or new symptoms. COPD is a serious and chronic lung condition. Two conditions can cause it: emphysema and chronic bronchitis.

For many in the Texas Panhandle, a groundbreaking procedure is offering a new lease on life ... is a minimally invasive treatment for severe or very severe COPD and emphysema.